CD8A and cancer: High densities of CD3+ / CD8+ TILs have been associated with improved survival and a favorable disease course in various cancers [8–11, 14, 15, 27, 28] and high CD3i levels have been identified as strong and independent prognosticators for example in human colorectal [14] and ovarian cancer [16, 17].